3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Refractory or Relapsed Solid Tumors
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Lethal Congenital Contracture Syndrome 2
1
Hematologic Neoplasms
1
Fallopian Tube Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Barrett Esophagus
1
Advanced Breast Cancer
1
Adenocarcinoma Of Esophagus
1
Interventions
pembrolizumab
60
Cisplatin
43
Cetuximab
25
Carboplatin
24
Paclitaxel
19
Magnetic Resonance Spectroscopy
18
Radiotherapy, Intensity-Modulated
17
Nivolumab
16
Radiotherapy
15
Specimen Handling
14
Docetaxel
13
Platinum
12
1,2-diaminocyclohexaneplatinum II citrate
11
Taxes
8
Fluorouracil
8
Biopsy
7
atezolizumab
6
Radiation
6
(225)Ac-DOTA-c(RGDyK)
6
dostarlimab
5
cemiplimab
5
Ipilimumab
5
Standard of Care
4
Immunoglobulin G
4
Disulfides
4
Cyclophosphamide
4
Bevacizumab
4
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
toripalimab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
Itraconazole
×
90 days
×
Clear all
No trials found.